Ingrid Goldberg | VP, IR |
William Doyle | Executive Chairman |
Ashley Cordova | CFO |
Asaf Danziger | President, CEO & Director |
Uri Weinberg | Chief Science Officer |
Pritesh Shah | Chief Commercial Officer |
Cory Kasimov | JPMorgan Chase & Co. |
Jason Bednar | Piper Sandler & Co. |
Gregory Fraser | Truist Securities |
Emily Bodnar | H.C. Wainwright & Co. |
Jason Wittes | Loop Capital Markets |
Good day, and welcome to the NovoCure Q2 2022 Earnings Call. [Operator Instructions].
As a reminder, this call is being recorded. I would now like to turn the call over to Ingrid Goldberg.
Good morning, everyone, and thank you for joining us to review NovoCure's second quarter 2022 performance.